Metabolic alterations in renal and prostate cancer

Chiara Ciccarese, Matteo Santoni, Francesco Massari, Alessandra Modena, Francesco Piva, Alessandro Conti, Roberta Mazzucchelli, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli, Giampaolo Tortora, Rodolfo Montironi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Cancer metabolism is emerging as a promising research area in genitourinary tumors. Both renal cell carcinoma (RCC) and prostate cancer (PCa) cells exhibit marked alterations of their metabolism. These changes include increased aerobic glycolysis (the Warburg effect), increased protein and DNA synthesis and de novo fatty acid (FA) synthesis. Objective: Understanding the molecular mechanisms underlying such alterations will represent a major step forward in cancer research. Indeed, reprogramming cancer cell energy metabolism represents a promising hallmark of cancer and may pave the way for novel personalized approaches. Method: PubMed databases were searched for articles published about cancer metabolism in genitourinary tumors. Results and Conclusion: This review is focused on the metabolic alterations that occur in RCC and PCa and describes the mechanisms underlying such metabolic changes.

Original languageEnglish (US)
Pages (from-to)150-155
Number of pages6
JournalCurrent Drug Metabolism
Volume17
Issue number2
StatePublished - Feb 1 2016

Fingerprint

Kidney Neoplasms
Metabolism
Prostatic Neoplasms
Cells
Tumors
Renal Cell Carcinoma
Neoplasms
Fatty Acids
DNA
Glycolysis
Research
PubMed
Proteins
Energy Metabolism
Databases

Keywords

  • Cancer metabolism
  • Glycolysis
  • Lipogenesis
  • Prostate cancer
  • Renal cell carcinoma
  • Warburg effect

ASJC Scopus subject areas

  • Pharmacology
  • Clinical Biochemistry

Cite this

Ciccarese, C., Santoni, M., Massari, F., Modena, A., Piva, F., Conti, A., ... Montironi, R. (2016). Metabolic alterations in renal and prostate cancer. Current Drug Metabolism, 17(2), 150-155.

Metabolic alterations in renal and prostate cancer. / Ciccarese, Chiara; Santoni, Matteo; Massari, Francesco; Modena, Alessandra; Piva, Francesco; Conti, Alessandro; Mazzucchelli, Roberta; Cheng, Liang; Lopez-Beltran, Antonio; Scarpelli, Marina; Tortora, Giampaolo; Montironi, Rodolfo.

In: Current Drug Metabolism, Vol. 17, No. 2, 01.02.2016, p. 150-155.

Research output: Contribution to journalArticle

Ciccarese, C, Santoni, M, Massari, F, Modena, A, Piva, F, Conti, A, Mazzucchelli, R, Cheng, L, Lopez-Beltran, A, Scarpelli, M, Tortora, G & Montironi, R 2016, 'Metabolic alterations in renal and prostate cancer', Current Drug Metabolism, vol. 17, no. 2, pp. 150-155.
Ciccarese C, Santoni M, Massari F, Modena A, Piva F, Conti A et al. Metabolic alterations in renal and prostate cancer. Current Drug Metabolism. 2016 Feb 1;17(2):150-155.
Ciccarese, Chiara ; Santoni, Matteo ; Massari, Francesco ; Modena, Alessandra ; Piva, Francesco ; Conti, Alessandro ; Mazzucchelli, Roberta ; Cheng, Liang ; Lopez-Beltran, Antonio ; Scarpelli, Marina ; Tortora, Giampaolo ; Montironi, Rodolfo. / Metabolic alterations in renal and prostate cancer. In: Current Drug Metabolism. 2016 ; Vol. 17, No. 2. pp. 150-155.
@article{16727bdba3c349bfb4c6af7e13d186f9,
title = "Metabolic alterations in renal and prostate cancer",
abstract = "Background: Cancer metabolism is emerging as a promising research area in genitourinary tumors. Both renal cell carcinoma (RCC) and prostate cancer (PCa) cells exhibit marked alterations of their metabolism. These changes include increased aerobic glycolysis (the Warburg effect), increased protein and DNA synthesis and de novo fatty acid (FA) synthesis. Objective: Understanding the molecular mechanisms underlying such alterations will represent a major step forward in cancer research. Indeed, reprogramming cancer cell energy metabolism represents a promising hallmark of cancer and may pave the way for novel personalized approaches. Method: PubMed databases were searched for articles published about cancer metabolism in genitourinary tumors. Results and Conclusion: This review is focused on the metabolic alterations that occur in RCC and PCa and describes the mechanisms underlying such metabolic changes.",
keywords = "Cancer metabolism, Glycolysis, Lipogenesis, Prostate cancer, Renal cell carcinoma, Warburg effect",
author = "Chiara Ciccarese and Matteo Santoni and Francesco Massari and Alessandra Modena and Francesco Piva and Alessandro Conti and Roberta Mazzucchelli and Liang Cheng and Antonio Lopez-Beltran and Marina Scarpelli and Giampaolo Tortora and Rodolfo Montironi",
year = "2016",
month = "2",
day = "1",
language = "English (US)",
volume = "17",
pages = "150--155",
journal = "Current Drug Metabolism",
issn = "1389-2002",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - Metabolic alterations in renal and prostate cancer

AU - Ciccarese, Chiara

AU - Santoni, Matteo

AU - Massari, Francesco

AU - Modena, Alessandra

AU - Piva, Francesco

AU - Conti, Alessandro

AU - Mazzucchelli, Roberta

AU - Cheng, Liang

AU - Lopez-Beltran, Antonio

AU - Scarpelli, Marina

AU - Tortora, Giampaolo

AU - Montironi, Rodolfo

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Background: Cancer metabolism is emerging as a promising research area in genitourinary tumors. Both renal cell carcinoma (RCC) and prostate cancer (PCa) cells exhibit marked alterations of their metabolism. These changes include increased aerobic glycolysis (the Warburg effect), increased protein and DNA synthesis and de novo fatty acid (FA) synthesis. Objective: Understanding the molecular mechanisms underlying such alterations will represent a major step forward in cancer research. Indeed, reprogramming cancer cell energy metabolism represents a promising hallmark of cancer and may pave the way for novel personalized approaches. Method: PubMed databases were searched for articles published about cancer metabolism in genitourinary tumors. Results and Conclusion: This review is focused on the metabolic alterations that occur in RCC and PCa and describes the mechanisms underlying such metabolic changes.

AB - Background: Cancer metabolism is emerging as a promising research area in genitourinary tumors. Both renal cell carcinoma (RCC) and prostate cancer (PCa) cells exhibit marked alterations of their metabolism. These changes include increased aerobic glycolysis (the Warburg effect), increased protein and DNA synthesis and de novo fatty acid (FA) synthesis. Objective: Understanding the molecular mechanisms underlying such alterations will represent a major step forward in cancer research. Indeed, reprogramming cancer cell energy metabolism represents a promising hallmark of cancer and may pave the way for novel personalized approaches. Method: PubMed databases were searched for articles published about cancer metabolism in genitourinary tumors. Results and Conclusion: This review is focused on the metabolic alterations that occur in RCC and PCa and describes the mechanisms underlying such metabolic changes.

KW - Cancer metabolism

KW - Glycolysis

KW - Lipogenesis

KW - Prostate cancer

KW - Renal cell carcinoma

KW - Warburg effect

UR - http://www.scopus.com/inward/record.url?scp=84958253869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958253869&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 150

EP - 155

JO - Current Drug Metabolism

JF - Current Drug Metabolism

SN - 1389-2002

IS - 2

ER -